metronidazole has been researched along with meropenem in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.37) | 18.7374 |
1990's | 9 (12.33) | 18.2507 |
2000's | 18 (24.66) | 29.6817 |
2010's | 29 (39.73) | 24.3611 |
2020's | 16 (21.92) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
Appelbaum, PC; Credito, KL; Ednie, LM | 1 |
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
Goto, T; Ichiishi, T; Mikamo, H; Nakao, K; Tanaka, K; Watanabe, K; Yamagishi, Y | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bishop, P; Wade, WG | 1 |
Naden, M; Watt, B | 1 |
Gerbracht, K; Manncke, B; Schumacher, U; Werner, H | 1 |
Cherubin, CE; Citron, DM; Goldstein, EJ; Hillier, SL | 1 |
Baker, LW; Hoogkamp-Korstanjep, JA; Huizinga, WK; Karran, SJ; Pezet, DM; Valleur, P; Warren, BL | 1 |
Schuler, D | 1 |
Dewar, EP; Leaper, DJ; Mehtar, S; Taylor, EW | 1 |
Schumacher, UK; Single, B | 1 |
Azanza, R; Caínzos, M; Díaz, J; Guirao, X; Jover, JM; Lizasoaín, M; Moreno Azcoita, M; Rodríguez Noriega, A; Sitges-Serra, A | 1 |
Chanis, W; Csapó, Z; Konkoly Thege, M; Pulay, I | 1 |
Cantalapiedra, A; Del Villar, R; García-Frade, LJ; Gutierrez, O; Peñarrubia, MJ; Sales, R; Tabuyo, MI | 1 |
Brooke, CJ; Hampson, DJ; Riley, TV | 1 |
Block, F; Foltys, H; Lemmen, SW; Spitzer, C | 1 |
Beloborodov, VB; Eliseeva, EV; Grigor'ev, KB; Iakovlev, SV; Iakovlev, VP; Kon, EM; Kostina, GV; Kuprenkov, AV; Levit, AL; Mukhacheva, SIu; Saturnov, AV; Sergeev, IN; Sidorenko, SV; Spasov, GP; Stakanov, AV; Ushakova, MA | 1 |
Abubaker, J; Khan, SG; Khursheed, M; Noman, F; Noor, SA | 1 |
Kumar, R; Sarin, SK; Sharma, P; Sundar, S | 1 |
Gupta, P; Gupta, R; Gupta, S; Jandial, K; Rana, V; Samotra, S; Singh, J | 1 |
Cheng, AC; Huysmans, M; Peel, T; Spelman, D; Spelman, T | 1 |
Elliott, L; Soo, SS; Sosin, MD; Taylor, GK | 1 |
Lipka, J; Lucasti, C; Popescu, I; Ramesh, MK; Sable, C | 1 |
Friedland, I; Hershberger, E; Lucasti, C; Miller, B; Solomkin, J; Steenbergen, J; Yankelev, S | 1 |
Almström, M; Eaton, S; Hall, NJ; Naji, H; Patkova, B; Pierro, A; Svensson, JF; Wester, T | 1 |
Ferrara, S; Gambino, A; Martines, F; Mucia, M; Salvago, P; Sireci, F | 1 |
Lai, J; Li, S; Liang, L; Peng, B; Wang, Z; Zheng, J | 1 |
Pineda, LC; Watt, KM | 1 |
Hakozaki, Y; Oya, M; Tanimoto, T; Yamamoto, T | 1 |
Adlan, T; He, J; Lam, JC | 1 |
Alby, K; Han, JH; Mills, JP; Talati, NJ | 1 |
Armstrong, J; Broadhurst, H; Gasink, LB; Llorens, L; Mazuski, JE; Newell, P; Pachl, J; Rank, D; Stone, GG | 1 |
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O | 1 |
Luthe, SK; Sato, R | 1 |
Chen, Q; Chow, JW; Kim, MJ; Laud, PJ; Nguyen, DA; Qin, X; Song, J; Stone, GG; Tran, BG; Wang, L | 1 |
Jensen, BH; Justesen, US; Krogfelt, KA; Petersen, AM; Sydenham, TV | 1 |
Ferløv-Schwensen, SA; Hansen, KCM; Hoegh, SV; Justesen, US; Sydenham, TV | 1 |
Cohen-Wolkowiez, M; Greenberg, RG; Rivera-Chaparro, ND | 1 |
Banerjee, A; Bennett, L; Morelli, T; Teng, E | 1 |
Akgul, O; Jean-Pierre, H; Justesen, US; Kulekci, G; Morris, T; Nagy, E; Soyletir, G; Ulger Toprak, N; Urban, E; Veloo, ACM; Wybo, I | 1 |
Hussar, DA | 1 |
Nielsen, SY; Nørskov-Lauritsen, N | 1 |
Jacqz-Aigrain, E; Leroux, S; Magréault, S; Storme, T; Touati, J | 1 |
AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
Mason, CY; Papineni, P; Sandhu, GS; Stubbins, D | 1 |
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N | 1 |
De Geyter, D; Declerck, B; Piérard, D; Van der Beken, Y; Wybo, I | 1 |
Forbes, JD; Kus, JV; Patel, SN | 1 |
Adhav, C; Kamat, S; Rodgers, P | 1 |
Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
Fujimaki, T; Hirata, S; Kobayashi, M; Takabatake, K; Ujihara, M; Wakiya, K | 1 |
Bensaci, M; Bruno, CJ; Chen, G; Chen, X; Du, X; Fan, J; Huntington, JA; Johnson, MG; Sun, F; Sun, Y; Wang, H; Wang, Y | 1 |
Dhanasekaran, S; Manoharan, SS; Selvadoss, PP | 1 |
Fu, J; Li, X; Lv, Q; Shi, X; Wan, X; Xu, Q | 1 |
Bensaci, M; Bruno, CJ; De Anda, C; Dementieva, N; Huntington, JA; Jackson, CA; Johnson, MG; Lonchar, J; Newland, J; Popejoy, MW; Rhee, EG; Su, FH | 1 |
Bourgeaud, J; Delabays, B; Ratano, D; Van den Bogaart, L | 1 |
Deng, T; Kong, W; Li, S; Shu, Y; Wu, Y | 1 |
Giske, CG; Justesen, US; Kahlmeter, G; Matuschek, E; Skaare, D; Stubhaug, TT; Sundsfjord, A | 1 |
Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
5 review(s) available for metronidazole and meropenem
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emphysematous gastritis and severe aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cholelithiasis; Cyclosporine; Emphysema; Female; Gastritis; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Meropenem; Methylprednisolone; Metronidazole; Middle Aged; T-Lymphocytes; Thienamycins; Tomography, X-Ray Computed | 2003 |
[Bacterial meningitis as a complication of Fusobacterium necroforum infection in adults].
Topics: Adult; Anti-Bacterial Agents; Blood Glucose; Cerebrospinal Fluid Proteins; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusobacterium necrophorum; Humans; Lactic Acid; Leukocyte Count; Lung Abscess; Meningitis, Bacterial; Meropenem; Metronidazole; Oculomotor Nerve Diseases; Otitis Media; Pharyngitis; Sepsis; Syndrome; Thienamycins | 2003 |
New antibiotic dosing in infants.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Thienamycins | 2015 |
Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Network Meta-Analysis; Tazobactam; Tigecycline | 2023 |
16 trial(s) available for metronidazole and meropenem
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cefotaxime; Drug Therapy, Combination; Drug Tolerance; Humans; Meropenem; Metronidazole; Middle Aged; Thienamycins; Treatment Outcome | 1995 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
A multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Female; Hospitalization; Humans; Male; Meropenem; Metronidazole; Middle Aged; Prospective Studies; Thienamycins; Treatment Outcome | 1997 |
[Prospective randomized trial of meropenem versus cefotaxime and metronidazole in the treatment of intraabdominal infections].
Topics: Abdomen; Abdominal Abscess; Adult; Aged; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Thienamycins | 1998 |
[Comparative study of meropenem and amikacin/metronidazole combination in the treatment of severe abdominal surgical infections].
Topics: Abdomen; Amikacin; Drug Combinations; Humans; Meropenem; Metronidazole; Surgical Wound Infection; Thienamycins | 1998 |
[Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Metronidazole; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Russia; Thienamycins; Treatment Outcome | 2006 |
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Placebos; Thienamycins; Treatment Outcome; Young Adult | 2013 |
Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.
Topics: Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome | 2014 |
Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial.
Topics: Abdominal Pain; Acute Disease; Adolescent; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Humans; Meropenem; Metronidazole; Pilot Projects; Recurrence; Thienamycins; Treatment Outcome | 2015 |
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Drug Combinations; Female; Humans; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Thienamycins; Treatment Outcome; Young Adult | 2016 |
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult | 2017 |
A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Double-Blind Method; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intraabdominal Infections; Male; Meropenem; Metronidazole; Middle Aged; Thienamycins; Treatment Outcome; Young Adult | 2017 |
Ceftazidime-avibactam plus metronidazole vs. meropenem in complicated intra-abdominal infections: Indian subset from RECLAIM.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Drug Combinations; Humans; Intraabdominal Infections; Meropenem; Metronidazole | 2022 |
A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; China; Double-Blind Method; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Tazobactam | 2022 |
Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Child; Escherichia coli; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Penicillanic Acid; Tazobactam | 2023 |
52 other study(ies) available for metronidazole and meropenem
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Colony Count, Microbial; Doripenem; Humans; Microbial Sensitivity Tests | 2008 |
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Doripenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vitro activity of meropenem and other agents against oral bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Meropenem; Metronidazole; Microbial Sensitivity Tests; Mouth; Penicillin Resistance; Penicillin V; Tetracycline; Thienamycins | 1992 |
The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clindamycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Thienamycins | 1989 |
In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
Topics: Ampicillin; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Humans; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 1994 |
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cefoxitin; Clindamycin; Drug Resistance, Microbial; Imipenem; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Thienamycins | 1993 |
Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clindamycin; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Meropenem; Metronidazole; Microbial Sensitivity Tests; Quinolones; Thienamycins | 1998 |
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Metronidazole; Moxifloxacin; Quinolines; Spirochaetales; Swine; Tetracycline; Thienamycins | 2003 |
"Moraxella lacunata" endocarditis treated with penicillin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Gentamicins; Humans; Male; Meropenem; Metronidazole; Moraxellaceae Infections; Penicillins; Protein Synthesis Inhibitors; Thienamycins; Vancomycin | 2008 |
Conservative management of liver abscess complicated by hepatogastric fistula.
Topics: Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Digestive System Fistula; Drainage; Gastric Fistula; Humans; Liver Abscess, Amebic; Liver Diseases; Male; Meropenem; Metronidazole; Rupture, Spontaneous; Thienamycins | 2011 |
Emphysematous pyelonephritis in the setting of diabetes mellitus.
Topics: Anti-Infective Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Emphysema; Escherichia coli; Escherichia coli Infections; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Meropenem; Metronidazole; Middle Aged; Pyelonephritis; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Urinary Tract Infections | 2011 |
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Topics: Adult; Age Factors; Aged; Bacteremia; Bone Marrow Transplantation; Case-Control Studies; Catheterization, Central Venous; Enterococcus; Female; Gastrointestinal Diseases; Hospitals; Humans; Hypoalbuminemia; Male; Meropenem; Metronidazole; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Phenotype; Risk Factors; Thienamycins; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2012 |
Complication of etanercept treatment for rheumatoid arthritis--purulent pericarditis caused by a commensal organism.
Topics: Aged; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Gram-Positive Bacteria; Humans; Immunoglobulin G; Meropenem; Metronidazole; Opportunistic Infections; Penicillin G; Pericarditis; Receptors, Tumor Necrosis Factor; Risk Factors; Thienamycins | 2012 |
Parietal subdural empyema as complication of acute odontogenic sinusitis: a case report.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Craniotomy; Diagnosis, Differential; Empyema, Subdural; Follow-Up Studies; Humans; Male; Maxillary Sinus; Meropenem; Metronidazole; Parietal Lobe; Sinusitis; Subdural Space; Thienamycins; Tomography, X-Ray Computed; Tooth Extraction; Treatment Outcome; Vancomycin | 2014 |
[Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
Topics: Animals; Anti-Bacterial Agents; Bile; Cefoperazone; Drug Combinations; Meropenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rabbits; Random Allocation; Sulbactam; Thienamycins | 2014 |
Lemierre's Syndrome Associated with Periodontal Injury-derived Odontogenic Infection that Did Not Respond to Meropenem.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Dyspnea; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Jugular Veins; Lemierre Syndrome; Male; Meropenem; Metronidazole; Periodontitis; Radiography, Thoracic; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome; Wound Infection | 2015 |
Clival osteomyelitis and hypoglossal nerve palsy--rare complications of Lemierre's syndrome.
Topics: Adolescent; Anti-Infective Agents; Anticoagulants; Cranial Fossa, Posterior; Fever; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Hypoglossal Nerve Diseases; Jugular Veins; Lemierre Syndrome; Male; Meropenem; Metronidazole; Osteomyelitis; Pharyngitis; Sepsis; Thienamycins; Treatment Outcome; Warfarin | 2015 |
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Fecal Incontinence; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Metronidazole; Middle Aged; Organ Transplantation; Respiration, Artificial; Risk Factors; Stem Cell Transplantation; Thienamycins; Time Factors; Vancomycin | 2016 |
Cecal Perforation Associated with Clostridium difficile Infection: A Case Report.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colon; Consciousness Disorders; Diarrhea; Female; Fever; Hemorrhage; Humans; Intestinal Perforation; Meropenem; Metronidazole; Pneumoperitoneum; Shock, Septic; Thienamycins; Tomography, X-Ray Computed | 2017 |
Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Child; Clindamycin; Denmark; Drug Resistance, Bacterial; Feces; Humans; Meropenem; Metronidazole; Microbial Sensitivity Tests; Microbiota; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Thienamycins | 2017 |
Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; beta-Lactamases; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Meropenem; Metronidazole; Real-Time Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thienamycins | 2017 |
Dosing antibiotics in neonates: review of the pharmacokinetic data.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Birth Weight; Body Size; Cephalosporins; Child; Clindamycin; Glycopeptides; Humans; Infant; Infant, Newborn; Medication Reconciliation; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2017 |
An unusual presentation of pulmonary embolism leading to infarction, cavitation, abscess formation and bronchopleural fistulation.
Topics: Abscess; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchial Fistula; Disease Progression; Drug Therapy, Combination; Humans; Infarction; Male; Meropenem; Metronidazole; Middle Aged; Pleural Diseases; Pneumonia; Pulmonary Embolism; Radiography, Thoracic; Rivaroxaban; Thienamycins; Treatment Outcome | 2018 |
A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Clindamycin; Disk Diffusion Antimicrobial Tests; Fluoroquinolones; Humans; Kuwait; Meropenem; Metronidazole; Moxifloxacin; Prevotella; Sulbactam; Thienamycins; Turkey | 2018 |
New Drugs 2018, part 3.
Topics: Acetates; Boronic Acids; Drug Approval; Drug Combinations; Fluoroquinolones; Humans; Meropenem; Metronidazole; Nitroimidazoles; Parathyroid Hormone-Related Protein; Peptides; Prostaglandins F, Synthetic; Quinazolines; Thienamycins; United States; United States Food and Drug Administration | 2018 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Limit of Detection; Male; Meropenem; Metronidazole; Pediatrics; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Pleuropulmonary and hepatic amoebic abscesses in a returning traveller.
Topics: Adult; Colombia; Entamoeba histolytica; Entamoebiasis; Heparin; Humans; Liver Abscess, Amebic; Male; Meropenem; Metronidazole; Mexico; Peru; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Travel-Related Illness; Treatment Outcome; United Kingdom; Young Adult | 2020 |
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers | 2020 |
Antimicrobial susceptibility testing of Eggerthella lenta blood culture isolates at a university hospital in Belgium from 2004 to 2018.
Topics: Actinobacteria; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Belgium; Blood; Clindamycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Meropenem; Metronidazole; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2021 |
Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Canada; Clindamycin; Laboratories; Meropenem; Metronidazole; Microbial Sensitivity Tests; Penicillins | 2021 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |
Aspiration Surgery with Appropriate Antibiotic Treatment Yields Favorable Outcomes for Bacterial Brain Abscess.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brain Abscess; Female; Humans; Male; Meropenem; Metronidazole; Middle Aged; Respiration Disorders; Retrospective Studies; Treatment Outcome | 2022 |
Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach.
Topics: Anti-Bacterial Agents; Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Aztreonam; Candida albicans; Candidiasis; Clindamycin; Drug Repositioning; Humans; Meropenem; Metronidazole | 2023 |
Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China.
Topics: Anti-Bacterial Agents; Ceftazidime; Cost-Benefit Analysis; Humans; Intraabdominal Infections; Meropenem; Metronidazole; Microbial Sensitivity Tests | 2023 |
Complex Lemierre syndrome with multisystemic abscesses.
Topics: Anti-Bacterial Agents; Brain Abscess; Ceftriaxone; Female; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Lemierre Syndrome; Meropenem; Metronidazole | 2023 |
Antimicrobial susceptibility testing of Bacteroides species by disk diffusion: The NordicAST Bacteroides study.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Horses; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |